Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy
Developmental Medicine & Child Neurology · 2025
DOI: 10.1111/dmcn.16198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, 2025. Verfasst von Linda Pax Lowes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gene Therapy, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Psychometrics, Patient Reported Outcome Measures, Parents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sarepta Therapeutics, Inc, Sarepta Therapeutics.
Themen: Mobilisation
Abstract (Originalsprache)
Aim
To evaluate the psychometric properties and measurement quality of the Patient‐Reported Outcomes Measurement Information System Parent Proxy (PROMIS PP) Mobility item bank (v1.0, 23 items) for children with Duchenne muscular dystrophy (DMD), through Rasch statistical analysis.
Method
De‐identified PROMIS PP Mobility items were completed by the caregivers of male patients with DMD, aged 4 to 12 years, as part of standard clinical care at the Nationwide Children's Hospital clinic; data were mined retrospectively from electronic health records. Rasch analysis was used to assess the internal functioning of the measure and items.
Results
Overall, 151 observations were available for the Rasch analysis, equally split between patients aged 4 to 7 years and 8 to 12 years. After removing clinically irrelevant items and regrouping response options for specific items, the resulting 19‐item measure demonstrated overall good fit to Rasch model expectations and the ability to discriminate between respondents with different mobility levels (Person Separation Index = 0.95, excellent reliability).
Interpretation
The customized PROMIS PP Mobility measure demonstrated good fit and may be a reliable option for mobility assessment in children with DMD. Rasch analysis can be used by other researchers to improve the sensitivity of patient‐reported outcomes in their field of interest.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Gene Therapy, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
- Biostatistics, Sainte-Anne, Guadeloupe, France.
- Patient-Centered Outcomes, Sarepta Therapeutics, Inc., Cambridge, MA, USA.
ORCID-Profile: Linda Pax Lowes, Lindsay N Alfano, Megan A Iammarino
Förderung
- Sarepta Therapeutics, Inc
- Sarepta Therapeutics
Zitieren
APA
Lowes, L. P., Le Reun, C. M., Alfano, L. N., Reash, N. F., Iammarino, M. A., Patel, S., & Audhya, I. F. (2025). Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.16198
Vancouver
Lowes LP, Le Reun CM, Alfano LN, Reash NF, Iammarino MA, Patel S, et al. Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy. Developmental Medicine & Child Neurology. 2025. doi:10.1111/dmcn.16198
BibTeX
@article{Lowes2025,
author = {Lowes, Linda Pax and Le Reun, Corinne M and Alfano, Lindsay N and Reash, Natalie F and Iammarino, Megan A and Patel, Shivangi and Audhya, Ivana F},
title = {Psychometric evaluation of the PROMIS parent proxy mobility item bank for use in Duchenne muscular dystrophy},
journal = {Developmental Medicine & Child Neurology},
year = {2025},
doi = {10.1111/dmcn.16198}
}
EUVIMED